Casdin Capital, LLC Sample Contracts
AGREEMENTSchedule 13d • March 7th, 2025 • Casdin Capital, LLC • Biological products, (no disgnostic substances)
The undersigned agree that this Schedule 13D, dated March 7, 2025, relating to the Common Stock, $0.0001 par value per share, of Tenaya Therapeutics, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13d Amendment • November 28th, 2025 • Casdin Capital, LLC • Laboratory analytical instruments
The undersigned agree that this Schedule 13D amendment, dated November 28, 2025, relating to the Common Stock, $0.001 par value per share, of Standard BioTools Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13d Amendment • October 17th, 2025 • Casdin Capital, LLC • Electromedical & electrotherapeutic apparatus
The undersigned agree that this Schedule 13D amendment, dated October 17, 2025, relating to the Common Stock, par value $0.001 per share of BioLife Solutions, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13d Amendment • April 9th, 2025 • Casdin Capital, LLC • Electromedical & electrotherapeutic apparatus
The undersigned agree that this Schedule 13D amendment, dated April 9, 2025, relating to the Common Stock, $0.001 par value of BioLife Solutions, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2025 • Casdin Capital, LLC • Pharmaceutical preparations
The undersigned agree that this Schedule 13G Amendment No. 1 dated February 14, 2025 relating to the Common Stock, $0.000001 par value, of Neurogene Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13d Amendment • August 21st, 2025 • Casdin Capital, LLC • Electromedical & electrotherapeutic apparatus
The undersigned agree that this Schedule 13D amendment, dated August 21, 2025, relating to the Common Stock, par value $0.001 per share of BioLife Solutions, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13d Amendment • June 12th, 2025 • Casdin Capital, LLC • Electromedical & electrotherapeutic apparatus
The undersigned agree that this Schedule 13D amendment, dated June 12, 2025, relating to the Common Stock, par value $0.001 per share of BioLife Solutions, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • August 14th, 2025 • Casdin Capital, LLC • Industrial organic chemicals
The undersigned agree that this Schedule 13G Amendment No. 1 dated August 14, 2025 relating to the Common Stock, par value $0.0001 per share, of Codexis, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • May 15th, 2025 • Casdin Capital, LLC • Biological products, (no disgnostic substances)
The undersigned agree that this Schedule 13G Amendment No. 1 dated May 15, 2025 relating to the Common Stock, $0.0001 par value per share, of Century Therapeutics, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13d Amendment • May 22nd, 2026 • Casdin Capital, LLC • Electromedical & electrotherapeutic apparatus
The undersigned agree that this Schedule 13D amendment, dated May 22, 2026, relating to the Common Stock, par value $0.001 per share of BioLife Solutions, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13d Amendment • March 4th, 2025 • Casdin Capital, LLC • Laboratory analytical instruments
The undersigned agree that this Schedule 13D amendment, dated March 4, 2025, relating to the Common Stock, par value $0.001 per share, of Standard BioTools Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13d Amendment • August 13th, 2025 • Casdin Capital, LLC • Electromedical & electrotherapeutic apparatus
The undersigned agree that this Schedule 13D amendment, dated August 13, 2025, relating to the Common Stock, par value $0.001 per share of BioLife Solutions, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • June 4th, 2026 • Casdin Capital, LLC • Electromedical & electrotherapeutic apparatus
The undersigned agree that this Schedule 13G dated June 4, 2026 relating to the Common Stock, par value $0.001 per share, of BioLife Solutions, Inc. shall be filed on behalf of the undersigned.
AGREEMENTSchedule 13d Amendment • June 9th, 2026 • Casdin Capital, LLC • Laboratory analytical instruments
The undersigned agree that this Schedule 13D amendment, dated June 9, 2026, relating to the Common Stock, par value $0.001 per share, of Standard BioTools Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 17th, 2026 • Casdin Capital, LLC • Biological products, (no disgnostic substances)
The undersigned agree that this Schedule 13G Amendment No. 2 dated February 17, 2026 relating to the Common Stock, par value $0.001 per share, of Relay Therapeutics, Inc. shall be filed on behalf of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • November 14th, 2025 • Casdin Capital, LLC • Industrial organic chemicals
The undersigned agree that this Schedule 13G Amendment No. 2 dated November 14, 2025 relating to the Common Stock, par value $0.0001 per share, of Codexis, Inc. shall be filed on behalf of the undersigned.